Cite
HARVARD Citation
Lowin, T. et al. (2016). The synthetic cannabinoid WIN55, 212-2 mesylate decreases the production of inflammatory mediators in rheumatoid arthritis synovial fibroblasts by activating CB2, TRPV1, TRPA1 and yet unidentified receptor targets. Journal of inflammation. 13 (1), pp. 1-10. [Online].